Galera Therapeutics Inc (GRTX) ニュース

Does anyone know how many employees they have? In December of 2023 they had 7. I am wondering what is happening.

Does anyone know how many employees they have? In December of 2023 they had 7. I am wondering what is happening.

Finally this scam is toast

GRTX delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

Waiting for less than $0.06..........

Maybe it’s time to jump back again !

GRTX under 25 cents

GRTX..........................................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783

GRTX..........................................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783

Creeping up, let’s do it again .

$GRTX

Over 11 million in volume with a high of .245 $

Sounds good
As of December 31, 2023, Galera had cash and cash equivalents of $18.3 million. Galera expects that its existing cash and cash equivalents will enable Galera to fund its operating expenses and capital expenditure requirements into the second quarter of 2025.

And some news will be great !

Need some volume !

Nice size bid !

Interesting price, I’m in
$GTRX

$GRTX - wants to move even higher...funds buying in? Anyone monitoring that? I need to find those links for Institutional reporting

GRTX............................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783

weeeee

Looks like a lot of people gave up and sold too low...it may punch UP further tomorrow...certainly held gains ah's. News pending?

13G 12% stake. Looks ready. Mc only 7 mill, cash and tangibles 28 mill. No cash needed until 2025. Buyout candidate IMO.

Close Watch: GRTX 8 x 34 + other daily technicals curling up. Now @0.14 - 0.15 > 0.1610 - 0.171(Parabolic SAR) >> 0.32, and then up to 0.50, +233% short-term target price.

GRTX @0.14 - 0.15 fwiw. "...risk/reward is still favorable. 28 mil cash on hand, and laying off over 70% of the workforce and stopping the 2 trials, should be ample enough money to carry them through all of 2024. Already have made it clear that they don't want to go through another trial for Avasopasem, as it is costly and time consuming, so if you are buying or going long here, you are simply playing[translation: ACCUMULATING, lol ] for one of the possible strategic maneuvers..."
Source: Click here.

TP: 0.25 min 0.50 max and/or 0.42 ave.(short-term TP = 3x or +200% from 0.14-.0.15 current pps) .

Source: 3 stock analysts. Click here.

GRTX...................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783

Why ? do you think it will go higher soon ?

Never see these prices again

lol you were telling peeps to dump few days ago

Dumped at .145..TY stock God's...In .0919

Seen this many times.This goose is cooked.Expect chapter 11 in the near future.Good luck and good trading.

You may as well unload now...geez.. what a fiasco

And in the case of IPIX like it is here with Galera, the FDA constantly wants more testing and more testing. But yet for an experimental MRNA shot which scientists and the medical community will not truly know the effects for another 5 years on one’s health, they green light. In my opinion, it’s all about who greases whose palms!!!

Overreaction??? This looks to be going down the route of IPIX. Both of these companies Galera and Innovation Pharma had a product for OM and both of them have been rejected by the FDA. It’s amazing to me the stupidity of how it goes especially since they have nothing that really works right now and patients that develop OM usually have to stop cancer treatments and then decide whether or not to continue once the symptoms subside and heal. And the cost for a severe OM patient to be treated is very, very expensive.

$GRTX where's the guy who was pumping this trash all over iHub?
Next stop is BK and delisting.

Do the company has any IP property for buyout/merger with all the trails cancellations...

Over reaction: GRTX, cash: $28.4 M. "Galera estimates that its balance of cash, cash equivalents and short-term investments as of September 30, 2023 was $28.4 million. or $0.7/share . "

Not bad??? Check out market reaction. Down 50% pre market.

News out, need to do another phase 3 tests and submit holding back other drug to save money… not bad

website is back up

Wow

Website is down...Whats going on

Should be hearing something this week

I bet so

It is possible to fill that $2 gap Omega... Depends on how good the news is...

...with Good Weather. lol

Fully loaded at an average.185

Early Christmas 🎄

Gap fill would be excellent.

fda news run to $2 tomorrow??